Supplementary Material for: Genetic epidemiology of amyotrophic lateral sclerosis in Norway – a 2-year population based study
Olsen C.G., Helle Høyer(Telemark Hospital), Katrin Schlüter, Jøntvedt A.B., H. L., Kristian Tveten(Telemark Hospital), Odd Nakken, Camilla Novy(University of Oslo), Grethe Kleveland(Innlandet Hospital Trust), Tiina Rekand(Haukeland University Hospital), Angelina Maniaol(Oslo University Hospital), Erika Hallerstig(Østfold Hospital Trust), Trygve Holmøy(OsloMet – Oslo Metropolitan University), Natasha Demic(Sykehuset i Vestfold), Flemmen H.Ø., Kampman M.T., Morsund Å.H., Busk Ø.L., Breivik K.L., Kvernmo H.B., Tysnes O.-B., Braathen G.J., Alstadhaug K.B., Bharath Vignesh R K, S. Schüler, Ineke Hogenesch(Privatsykehuset Haugesund), Aanjesen T.N., Unn Ljøstad(Sørlandet Sykehus)
Cited by 0
Related Papers
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
|The American Journal of Human Genetics|2017|202
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry
|European Heart Journal|2019|188
Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom
|Annals of Neurology|2016|125
Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies
|Genetics in Medicine|2018|91
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
|Multiple Sclerosis Journal|2015|76